An Iranian familial amyotrophic lateral sclerosis pedigree with p.Val48Phe causing mutation in SOD1: a genetic and clinical report

Objective(s): Amyotrophic lateral sclerosis (ALS), a fatal progressive neurodegenerative disorder, is the most common motor neuron disease in European populations. Approximately 10% of ALS cases are familial (FALS) and the other patients are considered as sporadic ALS (SALS). Among many ALS causing...

Full description

Bibliographic Details
Main Authors: Afagh Alavi, Marzieh Khani, Shahriar Nafissi, Hosein Shamshiri, Elahe Elahi
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2014-10-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:http://ijbms.mums.ac.ir/pdf_3443_c9ae74289f876dadd065b6cc07c38b14.html
_version_ 1818750213678956544
author Afagh Alavi
Marzieh Khani
Shahriar Nafissi
Hosein Shamshiri
Elahe Elahi
author_facet Afagh Alavi
Marzieh Khani
Shahriar Nafissi
Hosein Shamshiri
Elahe Elahi
author_sort Afagh Alavi
collection DOAJ
description Objective(s): Amyotrophic lateral sclerosis (ALS), a fatal progressive neurodegenerative disorder, is the most common motor neuron disease in European populations. Approximately 10% of ALS cases are familial (FALS) and the other patients are considered as sporadic ALS (SALS). Among many ALS causing genes that have been identified, mutations in SOD1 and C9orf72 are the most common genetic causes of the disease. In Iranian patients, it has been shown that SOD1, as compared to C9orf72, plays a much more prominent role.  To date, more than 170 mutations have been reported in SOD1. Genotype/phenotype correlation with respect to either different causative genes or different mutations of a specific gene has not been well established.  Materials and Methods: Five exons of SOD1 and flanking intronic sequences of an Iranian FALS proband were screened for mutations by direct sequencing. Also, the clinical features of the proband were described. Results: Heterozygous p.Val48Phe causing mutation was identified in SOD1. Age at onset was 29 years and site of the first presentation was the lower extremity in the proband. Conclusion: The p.Val48Phe causing mutation appears to cause early onset of ALS.
first_indexed 2024-12-18T04:16:03Z
format Article
id doaj.art-d042313a7bfc432cb69975a4d8fba717
institution Directory Open Access Journal
issn 2008-3866
2008-3874
language English
last_indexed 2024-12-18T04:16:03Z
publishDate 2014-10-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Basic Medical Sciences
spelling doaj.art-d042313a7bfc432cb69975a4d8fba7172022-12-21T21:21:22ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences2008-38662008-38742014-10-0117107357393443An Iranian familial amyotrophic lateral sclerosis pedigree with p.Val48Phe causing mutation in SOD1: a genetic and clinical reportAfagh Alavi0Marzieh Khani1Shahriar Nafissi2Hosein Shamshiri3Elahe Elahi4School of Biology, College of Science, University of Tehran, Tehran, IranSchool of Biology, College of Science, University of Tehran, Tehran, IranDepartment of Neurology, Tehran University of Medical Sciences, Tehran, IranDepartment of Neurology, Tehran University of Medical Sciences, Tehran, IranDepartment of Biotechnology, College of Science, University of Tehran, Tehran, IranObjective(s): Amyotrophic lateral sclerosis (ALS), a fatal progressive neurodegenerative disorder, is the most common motor neuron disease in European populations. Approximately 10% of ALS cases are familial (FALS) and the other patients are considered as sporadic ALS (SALS). Among many ALS causing genes that have been identified, mutations in SOD1 and C9orf72 are the most common genetic causes of the disease. In Iranian patients, it has been shown that SOD1, as compared to C9orf72, plays a much more prominent role.  To date, more than 170 mutations have been reported in SOD1. Genotype/phenotype correlation with respect to either different causative genes or different mutations of a specific gene has not been well established.  Materials and Methods: Five exons of SOD1 and flanking intronic sequences of an Iranian FALS proband were screened for mutations by direct sequencing. Also, the clinical features of the proband were described. Results: Heterozygous p.Val48Phe causing mutation was identified in SOD1. Age at onset was 29 years and site of the first presentation was the lower extremity in the proband. Conclusion: The p.Val48Phe causing mutation appears to cause early onset of ALS.http://ijbms.mums.ac.ir/pdf_3443_c9ae74289f876dadd065b6cc07c38b14.htmlALS Aamyotrophic lateral sclerosis SOD1 Superoxide dismutase 1 gene p.Val48Phe
spellingShingle Afagh Alavi
Marzieh Khani
Shahriar Nafissi
Hosein Shamshiri
Elahe Elahi
An Iranian familial amyotrophic lateral sclerosis pedigree with p.Val48Phe causing mutation in SOD1: a genetic and clinical report
Iranian Journal of Basic Medical Sciences
ALS Aamyotrophic lateral sclerosis SOD1 Superoxide dismutase 1 gene p.Val48Phe
title An Iranian familial amyotrophic lateral sclerosis pedigree with p.Val48Phe causing mutation in SOD1: a genetic and clinical report
title_full An Iranian familial amyotrophic lateral sclerosis pedigree with p.Val48Phe causing mutation in SOD1: a genetic and clinical report
title_fullStr An Iranian familial amyotrophic lateral sclerosis pedigree with p.Val48Phe causing mutation in SOD1: a genetic and clinical report
title_full_unstemmed An Iranian familial amyotrophic lateral sclerosis pedigree with p.Val48Phe causing mutation in SOD1: a genetic and clinical report
title_short An Iranian familial amyotrophic lateral sclerosis pedigree with p.Val48Phe causing mutation in SOD1: a genetic and clinical report
title_sort iranian familial amyotrophic lateral sclerosis pedigree with p val48phe causing mutation in sod1 a genetic and clinical report
topic ALS Aamyotrophic lateral sclerosis SOD1 Superoxide dismutase 1 gene p.Val48Phe
url http://ijbms.mums.ac.ir/pdf_3443_c9ae74289f876dadd065b6cc07c38b14.html
work_keys_str_mv AT afaghalavi aniranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport
AT marziehkhani aniranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport
AT shahriarnafissi aniranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport
AT hoseinshamshiri aniranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport
AT elaheelahi aniranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport
AT afaghalavi iranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport
AT marziehkhani iranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport
AT shahriarnafissi iranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport
AT hoseinshamshiri iranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport
AT elaheelahi iranianfamilialamyotrophiclateralsclerosispedigreewithpval48phecausingmutationinsod1ageneticandclinicalreport